News

  • Clarit study First patients enrolled in Spain

    First patients enrolled in the CLARIT trial

    -

    The CLARIT trial has reached an important milestone with the enrollment of its first patients in Spain. The first three patients were enrolled by Dr. Alfonso Jurado Román and the team at La Paz University Hospital in Madrid, marking the start of patient recruitment in Spain for this international...

  • LAARC Consensus

    LAARC consensus published in the European Heart Journal

    -

    Cardiovascular European Research Center (CERC) is proud to announce the publication of the Left Atrial Appendage Academic Research Consortium (LAARC) consensus in the European Heart Journal. Developed over three years through an international collaborative effort, this landma rk publication...

  • First German patient enrolled in the Leave Nothing Behind study

    New milestone in Leave Nothing Behind Study

    -

    We are pleased to celebrate another important milestone in the LNB Study! Congratulations to Prof. Dr. Holger Nef and the team in Herz- und Gefäßzentrum Segeberger Kliniken Gruppe on enrolling their first patient in the study. This marks an exciting step forward and reflects the team's commitment to...

  • Vitus study enrollment completed

    All patients enrolled in the VITUS study!

    -

    We are proud to announce the successful completion of patient enrollment in the VITUS study. This important milestone reflects the dedication, collaboration, and commitment of all participating investigators, study coordinators, and site teams who made this achievement possible. A sincere thank you...

  • EuroPCR 2026

    EuroPCR 2026: A Week of Scientific Exchange and Collaboration

    -

    EuroPCR 2026: A Week of Scientific Exchange and Collaboration EuroPCR 2026 has come to an end after an intense week of scientific discussions, investigator meetings and international collaboration across the cardiovascular research community. Throughout the congress, CERC was strongly represented in...

  • CERC at euroPCR 2026

    EuroPCR 2026 is almost here

    -

    This year again, CERC will be strongly represented throughout the congress with multiple scientific sessions, late-breaking presentations and investigator discussions across interventional cardiology and structural heart disease. Our teams will be present during the entire congress to connect with...

  • First UK patient enrolled in the START YOUNG study

    First UK patient enrolled in the START YOUNG study

    -

    A key milestone that marks strong momentum for the study across participating countries. Congratulations to Dr. Nishant Gangil, Dr. Thirumaran Rajathurai and the cath lab team at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust for this achievement. A great step forward driven by...

  • the first two patients in the TACTIC study

    First patients enrolled in the TACTIC study

    -

    We are pleased to announce the inclusion of the first two patients in the TACTIC study. The first patient was enrolled by Prof Alaide Chieffo from Ospedale San Raffaele, Milan, followed by a second inclusion by Dr Mario Iannaccone from San Giovanni Bosco Hospital, Turin. TACTIC study is an...

  •  Prof. Roxana Mehran on her appointment as President of the American College of Cardiology for 2026

    Celebrating Leadership: Prof. Roxana Mehran as ACC President 2026

    -

    The entire CERC team extends our sincere congratulations to Prof. Roxana Mehran on her appointment as President of the American College of Cardiology for 2026. Prof. Mehran’s leadership, vision, and enduring contributions to cardiovascular medicine and clinical research continue to shape the field...

  • CERC at ACC 26 & Prof Roxana Mehran new ACC president

    CERC continues to expand its footprint within the global cardiovascular community at ACC Congress 2026 in New Orleans

    -

    CERC continues to expand its footprint within the global cardiovascular community at ACC Congress 2026 in New Orleans As a physician-driven, full-service CRO, CERC continues to support the design and execution of innovative clinical trials that address key unmet needs in cardiovascular medicine....